Literature DB >> 9330553

Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS.

A W Wu1, R D Hays, S Kelly, F Malitz, S A Bozzette.   

Abstract

The leading health status instruments in human immunodeficiency virus (HIV) research are based on the pool of items developed as part of the Medical Outcomes Study (MOS). The measures include the SF-20, MOS-HIV, SF-36, SF-12, SF-56, SF-38 (Patient Reported Status and Experience Survey (PARSE)), SF-21 and HIV Cost and Service Utilization Study (HCSUS) questionnaires. The instrument length ranges from 12 to 56 items, covering two to 11 dimensions. Completion requires from 2 to 14 minutes. Subscales are scored on a 0-100 scale (a higher score indicates better health); physical and mental health or overall summary scores are available for most of the measures. Three of the instruments are available in multiple languages. The instruments have been administered to over 20,000 persons with HIV in descriptive studies and clinical trials and there is substantial evidence for their reliability, construct and predictive validity and responsiveness. In several studies the measures have shown important differences between treatments. Although existing measures do not assess all domains relevant to HIV disease, additional subscales are available from the MOS pool. Some of the subscales may be prone to floor and ceiling effects. However, summary scales that encompass all of the subscales reduce this issue. Selection among MOS measures should be dictated by specific questions, the balance of available time and resources, and practical concerns.

Entities:  

Mesh:

Year:  1997        PMID: 9330553     DOI: 10.1023/a:1018460132567

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  55 in total

1.  The Functional Status Questionnaire: reliability and validity when used in primary care.

Authors:  A M Jette; A R Davies; P D Cleary; D R Calkins; L V Rubenstein; A Fink; J Kosecoff; R T Young; R H Brook; T L Delbanco
Journal:  J Gen Intern Med       Date:  1986 May-Jun       Impact factor: 5.128

2.  The MOS short-form general health survey. Reliability and validity in a patient population.

Authors:  A L Stewart; R D Hays; J E Ware
Journal:  Med Care       Date:  1988-07       Impact factor: 2.983

3.  Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

Authors:  J M Jacobson; J S Greenspan; J Spritzler; N Ketter; J L Fahey; J B Jackson; L Fox; M Chernoff; A W Wu; L A MacPhail; G J Vasquez; D A Wohl
Journal:  N Engl J Med       Date:  1997-05-22       Impact factor: 91.245

4.  The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population.

Authors:  E A O'Keefe; R Wood
Journal:  Qual Life Res       Date:  1996-04       Impact factor: 4.147

5.  The prospective effect of access to medical care on health-related quality-of-life outcomes in patients with symptomatic HIV disease.

Authors:  W E Cunningham; R D Hays; M K Ettl; W J Dixon; R C Liu; C K Beck; M F Shapiro
Journal:  Med Care       Date:  1998-03       Impact factor: 2.983

6.  Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection.

Authors:  A W Wu; H R Rubin; W C Mathews; L M Brysk; S A Bozzette; W D Hardy; J H Atkinson; I Grant; S A Spector; J A McCutchan
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-05

7.  Health-related quality of life in persons with acquired immune deficiency syndrome.

Authors:  P D Cleary; F J Fowler; J Weissman; M P Massagli; I Wilson; G R Seage; C Gatsonis; A Epstein
Journal:  Med Care       Date:  1993-07       Impact factor: 2.983

8.  A Perceived Health Index for use in persons with advanced HIV disease: derivation, reliability, and validity.

Authors:  S A Bozzette; R D Hays; S H Berry; D E Kanouse
Journal:  Med Care       Date:  1994-07       Impact factor: 2.983

9.  Derivation and properties of a brief health status assessment instrument for use in HIV disease.

Authors:  S A Bozzette; R D Hays; S H Berry; D E Kanouse; A W Wu
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-03-01

10.  Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning.

Authors:  J Tsevat; J G Solzan; K M Kuntz; J Ragland; J S Currier; R L Sell; M C Weinstein
Journal:  Med Care       Date:  1996-01       Impact factor: 2.983

View more
  99 in total

Review 1.  Cost effectiveness of combination HIV therapy: 3 years later.

Authors:  R D Moore
Journal:  Pharmacoeconomics       Date:  2000-04       Impact factor: 4.981

2.  Item response theory and health outcomes measurement in the 21st century.

Authors:  R D Hays; L S Morales; S P Reise
Journal:  Med Care       Date:  2000-09       Impact factor: 2.983

3.  Psychometric evaluation of the HIV symptom distress scale.

Authors:  Linda G Marc; Ming-Mei Wang; Marcia A Testa
Journal:  AIDS Care       Date:  2012-03-12

4.  Reliability and validity of the SF-36 in HIV-infected homeless and marginally housed individuals.

Authors:  E D Riley; D R Bangsberg; S Perry; R A Clark; A R Moss; A W Wu
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

5.  Quality of life among adults with confirmed dengue in Brazil.

Authors:  Celina Maria Turchi Martelli; Nazareth Elias Nascimento; Jose A Suaya; Joao Bosco Siqueira; Wayner Vieira Souza; Marilia Dalva Turchi; Adriana Oliveira Guilarde; Joao Borges Peres; Donald S Shepard
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

6.  The HIV Medication Taking Self-efficacy Scale: psychometric evaluation.

Authors:  Judith A Erlen; Eun Seok Cha; Kevin H Kim; Donna Caruthers; Susan M Sereika
Journal:  J Adv Nurs       Date:  2010-08-16       Impact factor: 3.187

7.  Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS.

Authors:  Knut Stavem; Stig S Frøland; Kjell B Hellum
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

8.  Exploring lack of trust in care providers and the government as a barrier to health service use.

Authors:  Kathryn Whetten; Jane Leserman; Rachel Whetten; Jan Ostermann; Nathan Thielman; Marvin Swartz; Dalene Stangl
Journal:  Am J Public Health       Date:  2006-02-28       Impact factor: 9.308

9.  Quality of life among people treated for tuberculosis and human immunodeficiency virus in Rio de Janeiro, Brazil.

Authors:  D W Dowdy; G Israel; V Vellozo; V Saraceni; S Cohn; S Cavalcante; R E Chaisson; J E Golub; B Durovni
Journal:  Int J Tuberc Lung Dis       Date:  2013-01-14       Impact factor: 2.373

10.  The combined effect of relaxation response and acupuncture on quality of life in patients with HIV: a pilot study.

Authors:  Bei-Hung Chang; Ulrike Boehmer; Yue Zhao; Elizabeth Sommers
Journal:  J Altern Complement Med       Date:  2007-10       Impact factor: 2.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.